96 related articles for article (PubMed ID: 19144125)
41. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins.
Mentis GZ; Gravell M; Hamilton R; Shneider NA; O'Donovan MJ; Schubert M
J Neurosci Methods; 2006 Oct; 157(2):208-17. PubMed ID: 16725205
[TBL] [Abstract][Full Text] [Related]
42. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
[TBL] [Abstract][Full Text] [Related]
43. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
44. Lentiviral vectors for use in the central nervous system.
Jakobsson J; Lundberg C
Mol Ther; 2006 Mar; 13(3):484-93. PubMed ID: 16403676
[TBL] [Abstract][Full Text] [Related]
45. Gene-based treatment of motor neuron diseases.
Federici T; Boulis NM
Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
[TBL] [Abstract][Full Text] [Related]
46. Altering the tropism of lentiviral vectors through pseudotyping.
Cronin J; Zhang XY; Reiser J
Curr Gene Ther; 2005 Aug; 5(4):387-98. PubMed ID: 16101513
[TBL] [Abstract][Full Text] [Related]
47. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.
Ralph GS; Radcliffe PA; Day DM; Carthy JM; Leroux MA; Lee DC; Wong LF; Bilsland LG; Greensmith L; Kingsman SM; Mitrophanous KA; Mazarakis ND; Azzouz M
Nat Med; 2005 Apr; 11(4):429-33. PubMed ID: 15768029
[TBL] [Abstract][Full Text] [Related]
48. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons.
Vincent AM; McLean LL; Backus C; Feldman EL
FASEB J; 2005 Apr; 19(6):638-40. PubMed ID: 15677696
[TBL] [Abstract][Full Text] [Related]
49. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
50. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.
Azzouz M; Le T; Ralph GS; Walmsley L; Monani UR; Lee DC; Wilkes F; Mitrophanous KA; Kingsman SM; Burghes AH; Mazarakis ND
J Clin Invest; 2004 Dec; 114(12):1726-31. PubMed ID: 15599397
[TBL] [Abstract][Full Text] [Related]
51. Factors influencing the titer and infectivity of lentiviral vectors.
Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB
Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113
[TBL] [Abstract][Full Text] [Related]
52. Lentiviral vectors for treating and modeling human CNS disorders.
Azzouz M; Kingsman SM; Mazarakis ND
J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068
[TBL] [Abstract][Full Text] [Related]
53. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Tanase K; Teng Q; Krishnaney AA; Liu JK; Garrity-Moses ME; Boulis NM
J Neurosurg Spine; 2004 Jul; 1(1):128-36. PubMed ID: 15291033
[TBL] [Abstract][Full Text] [Related]
54. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
55. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
Azzouz M; Ralph S; Wong LF; Day D; Askham Z; Barber RD; Mitrophanous KA; Kingsman SM; Mazarakis ND
Neuroreport; 2004 Apr; 15(6):985-90. PubMed ID: 15076720
[TBL] [Abstract][Full Text] [Related]
56. Transduction patterns of pseudotyped lentiviral vectors in the nervous system.
Wong LF; Azzouz M; Walmsley LE; Askham Z; Wilkes FJ; Mitrophanous KA; Kingsman SM; Mazarakis ND
Mol Ther; 2004 Jan; 9(1):101-11. PubMed ID: 14741783
[TBL] [Abstract][Full Text] [Related]
57. An improved beta-galactosidase reporter gene.
Anson DS; Limberis M
J Biotechnol; 2004 Feb; 108(1):17-30. PubMed ID: 14741766
[TBL] [Abstract][Full Text] [Related]
58. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
59. Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery.
Boulis NM; Noordmans AJ; Song DK; Imperiale MJ; Rubin A; Leone P; During M; Feldman EL
Neurobiol Dis; 2003 Dec; 14(3):535-41. PubMed ID: 14678769
[TBL] [Abstract][Full Text] [Related]
60. Small- to large-scale production of lentivirus vectors.
Marino MP; Luce MJ; Reiser J
Methods Mol Biol; 2003; 229():43-55. PubMed ID: 12824620
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
